☰

Stefano Tiziani, Ph.D. - Publications

Affiliations: 
2006 Ohio State University, Columbus, Columbus, OH 
Area:
Food Science and Technology Agriculture
Tree Info Similar researchers PubMed Report error

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Konopleva M, DiNardo C, Bhagat T, Baran N, Lodi A, Saxena K, Cai T, Su X, Skwarska A, Guerra V, Kuruvilla V, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, ... ... Tiziani S, et al. Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses. Research Square. PMID 36865338 DOI: 10.21203/rs.3.rs-2518774/v1  0.639
2023 Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, Kantarjian HM, Ravandi F, Collins ME, Francesco MED, Dumbrava EE, Fu S, Gao S, Gay JP, Gera S, ... ... Tiziani S, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature Medicine. PMID 36658425 DOI: 10.1038/s41591-022-02103-8  0.622
2022 Hua X, Li Y, Pentaparthi SR, McGrail DJ, Zou R, Guo L, Shrawat A, Cirillo KM, Li Q, Bhat AV, Xu M, Qi D, Singh A, McGrath F, Andrews SB, ... ... Tiziani S, et al. Landscape of microRNA regulatory network architecture and functional rerouting in cancer. Cancer Research. PMID 36265133 DOI: 10.1158/0008-5472.CAN-20-0371  0.576
2022 Lodi A, Pandey R, Chiou J, Bhattacharya A, Huang S, Pan X, Burgman B, Yi SS, Tiziani S, Brenner AJ. Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide. Frontiers in Oncology. 12: 900082. PMID 36226069 DOI: 10.3389/fonc.2022.900082  0.643
2022 Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, Pandey R, Skwarska A, Patel S, Tremblay M, Kuruvilla VM, Cavazos A, Kaplan M, Warmoes MO, Veiga DT, ... ... Tiziani S, et al. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nature Communications. 13: 2801. PMID 35589701 DOI: 10.1038/s41467-022-30396-3  0.663
2022 Lu X, Hackman GL, Saha A, Rathore AS, Collins M, Friedman C, Yi SS, Matsuda F, DiGiovanni J, Lodi A, Tiziani S. Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry. Iscience. 25: 104221. PMID 35494234 DOI: 10.1016/j.isci.2022.104221  0.596
2022 Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K, Grosskurth SE, Vijay P, ... ... Tiziani S, et al. Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduction and Targeted Therapy. 7: 110. PMID 35365596 DOI: 10.1038/s41392-022-00958-4  0.608
2022 Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K, Grosskurth SE, Vijay P, ... ... Tiziani S, et al. Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduction and Targeted Therapy. 7: 51. PMID 35185150 DOI: 10.1038/s41392-021-00870-3  0.637
2021 Gries P, Rathore AS, Lu X, Chiou J, Huynh YB, Lodi A, Tiziani S. Automated Trimethyl Sulfonium Hydroxide Derivatization Method for High-Throughput Fatty Acid Profiling by Gas Chromatography-Mass Spectrometry. Molecules (Basel, Switzerland). 26. PMID 34684827 DOI: 10.3390/molecules26206246  0.582
2021 Zavorka Thomas ME, Lu X, Talebi Z, Jeon JY, Buelow DR, Gibson AA, Uddin ME, Brinton LT, Nguyen J, Collins M, Lodi A, Sweeney SR, Campbell MJ, Sweet DH, Sparreboom A, ... ... Tiziani S, et al. Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD-positive AML. Molecular Cancer Therapeutics. PMID 34518298 DOI: 10.1158/1535-7163.MCT-21-0071  0.674
2021 Lu X, Han L, Busquets J, Collins M, Lodi A, Marszalek JR, Konopleva M, Tiziani S. The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells. Frontiers in Oncology. 11: 686765. PMID 34490088 DOI: 10.3389/fonc.2021.686765  0.664
2021 Pandey R, Collins M, Lu X, Sweeney SR, Chiou J, Lodi A, Tiziani S. Novel Strategy for Untargeted Chiral Metabolomics using Liquid Chromatography-High Resolution Tandem Mass Spectrometry. Analytical Chemistry. PMID 33818082 DOI: 10.1021/acs.analchem.0c05325  0.621
2021 Stanford SM, Collins M, Diaz MA, Holmes ZJ, Gries P, Bliss MR, Lodi A, Zhang V, Tiziani S, Bottini N. The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy. Journal of Cellular Physiology. PMID 33615467 DOI: 10.1002/jcp.30307  0.609
2020 Hackman GL, Collins M, Lu X, Lodi A, DiGiovanni J, Tiziani S. Predicting and Quantifying Antagonistic Effects of Natural Compounds Given with Chemotherapeutic Agents: Applications for High-Throughput Screening. Cancers. 12. PMID 33322034 DOI: 10.3390/cancers12123714  0.614
2020 Choudhury FK, Hackman GL, Lodi A, Tiziani S. Stable Isotope Tracing Metabolomics to Investigate the Metabolic Activity of Bioactive Compounds for Cancer Prevention and Treatment. Cancers. 12. PMID 32756373 DOI: 10.3390/Cancers12082147  0.685
2020 Lu WC, Saha A, Yan W, Garrison K, Lamb C, Pandey R, Irani S, Lodi A, Lu X, Tiziani S, Zhang YJ, Georgiou G, DiGiovanni J, Stone E. Enzyme-mediated depletion of serum l-Met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity. Proceedings of the National Academy of Sciences of the United States of America. PMID 32434918 DOI: 10.1073/Pnas.1917362117  0.635
2020 Sweeney SR, Collins M, Pandey R, Chiou J, Lodi A, Tiziani S. Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor-B cell acute lymphoblastic leukemia. Molecular Carcinogenesis. PMID 32027051 DOI: 10.1002/Mc.23163  0.713
2020 Thomas MZ, Jeon JY, Shabana S, Buelow D, Gibson A, Anderson J, Campbell M, Collins M, Lodi A, Sweeney S, Tiziani S, Sparreboom A, Baker S. Gilteritinib Inhibits Acute Myeloid Leukemia Growth via Reduction in Glutamine Uptake and Utilization The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04281  0.628
2019 Lu X, Lodi A, Konopleva M, Tiziani S. Three-Dimensional Leukemia Co-Culture System for In Vitro High-Content Metabolomics Screening. Slas Discovery : Advancing Life Sciences R & D. 2472555219860446. PMID 31345091 DOI: 10.1177/2472555219860446  0.64
2019 Sanchez-Lopez E, Zhong Z, Stubelius A, Sweeney SR, Booshehri LM, Antonucci L, Liu-Bryan R, Lodi A, Terkeltaub R, Lacal JC, Murphy AN, Hoffman HM, Tiziani S, Guma M, Karin M. Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production. Cell Metabolism. PMID 30982734 DOI: 10.1016/J.Cmet.2019.03.011  0.63
2019 Baran N, Lodi A, Sweeney SR, Kuruvilla VM, Cavazos A, Herranz D, Skwarska A, Warmoes M, Davis E, Harutyunyan K, Feng N, Gay JP, Kaminski M, Konoplev S, Jabbour E, ... ... Tiziani S, et al. Glutaminase Inhibition Overcomes Acquired Resistance to Mitochondrial Complex I in NOTCH1-Driven T-Cell Acute Lymphoblastic Leukemias (T-ALL) Via Block of Glutamine Driven Reductive Metabolism Blood. 134: 806-806. DOI: 10.1182/Blood-2019-128930  0.685
2019 Zhang Q, Lodi A, Sweeney SR, Han L, Cai T, Kuruvilla VM, Cavazos A, Ma H, Tabe Y, Marszalek JR, Tiziani S, Konopleva MY. Inhibiting Mitochondria Function By Bcl-2 Inhibitor Venetoclax and Complex I Inhibitor Iacs-010759 Eliminate Leukemia Cells in Pre-Clinical AML Models Blood. 134: 3927-3927. DOI: 10.1182/Blood-2019-124494  0.683
2019 Gruslova A, Lodi A, Li M, Zhou M, Garcia M, Tiziani S, Brenner A, Caflisch L. CBMT-39. TARGETING METABOLIC PATHWAYS IN HYPOXIA FOR GLIOBLASTOMA Neuro-Oncology. 21: vi41-vi41. DOI: 10.1093/Neuonc/Noz175.161  0.696
2018 Narasimhan R, Coras R, Rosenthal SB, Sweeney SR, Lodi A, Tiziani S, Boyle D, Kavanaugh A, Guma M. Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis. Arthritis Research & Therapy. 20: 164. PMID 30075744 DOI: 10.1186/S13075-018-1655-3  0.635
2018 Triplett TA, Garrison KC, Marshall N, Donkor M, Blazeck J, Lamb C, Qerqez A, Dekker JD, Tanno Y, Lu WC, Karamitros CS, Ford K, Tan B, Zhang XM, McGovern K, ... ... Tiziani S, et al. Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme. Nature Biotechnology. PMID 30010674 DOI: 10.1038/Nbt.4180  0.326
2018 Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA, Al-Atrash G, Asara J, Bardenhagen J, Carrillo CC, Carroll C, ... ... Tiziani S, et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nature Medicine. PMID 29892070 DOI: 10.1038/S41591-018-0052-4  0.683
2018 Falconer J, Murphy AN, Young S, Clark AR, Tiziani S, Guma M, Buckley CD. Synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29579371 DOI: 10.1002/Art.40504  0.372
2018 Bryant JD, Sweeney SR, Sentandreu E, Shin M, Ipas H, Xhemalce B, Momb J, Tiziani S, Appling DR. Deletion of the neural tube defect-associated genedisrupts one-carbon and central energy metabolism in mouse embryos. The Journal of Biological Chemistry. PMID 29483189 DOI: 10.1074/Jbc.Ra118.002180  0.362
2018 Brenner A, Zuniga R, Sun JD, Floyd J, Hart CP, Kroll S, Fichtel L, Cavazos D, Caflisch L, Gruslova A, Lodi A, Tiziani S. Hypoxia Activated Evofosfamide for Treatment of Recurrent Bevacizumab-Refractory Glioblastoma: A phase I surgical study. Neuro-Oncology. PMID 29415215 DOI: 10.1093/Neuonc/Noy015  0.631
2018 Baran N, Lodi A, Sweeney SR, Renu P, Kuruvilla VM, Cavazos A, Herranz D, Skwarska A, Warmoes M, Davis RE, Harutyunyan K, Feng N, Gay JP, Konoplev SN, Kaminski M, ... ... Tiziani S, et al. Mitochondrial Complex I Inhibitor Iacs-010759 Reverses the NOTCH1-Driven Metabolic Reprogramming in T-ALL Via Blockade of Oxidative Phosphorylation: Synergy with Chemotherapy and Glutaminase Inhibition Blood. 132: 4020-4020. DOI: 10.1182/Blood-2018-99-117310  0.695
2018 Konopleva MY, Lorenzi PL, Ghotbaldini S, Tabe Y, Cai T, Tiziani S. Contribution of Amino Acid Metabolism to Hematologic Malignancies Blood. 132: SCI-10-SCI-10. DOI: 10.1182/Blood-2018-99-109469  0.449
2018 Winikka L, Quach D, Harlow B, Brenner A, Munoz N, Tiziani S, deGraffenried L. Abstract P1-03-12: The ratio of omega-3 to omega-6 PUFAs impact cancer cell phenotype in the tumor microenvironment Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-03-12  0.351
2018 Kshattry S, Georgiou G, Tiziani S, Saha A, Stone E, DiGiovanni J. Abstract 3963: Cystine depleting human enzyme combined with auranofin synergistically inhibits pancreatic cancer cell growth in vitro and in vivo Cancer Research. 78: 3963-3963. DOI: 10.1158/1538-7445.Am2018-3963  0.383
2018 Baran N, Lodi A, Sweeney S, Kuruvilla VM, Cavazos A, Skwarska A, Velandy SS, Harutyunyan K, Feng N, Kaminski M, Jabbour EJ, Ferrando A, Francesco MED, Marszalek JR, Tiziani S, et al. Abstract 1875: Oxidative metabolism as a novel therapeutic target to eradicate T-ALL with mitochondrial complex I inhibitor IACS-010759 Cancer Research. 78: 1875-1875. DOI: 10.1158/1538-7445.Am2018-1875  0.696
2018 Caflisch L, Gruslova A, Garcia M, Lodi A, Tiziani S, Brenner AJ. Cbmt-11. Peroxisomal Fatty Acid Oxidation In Glioblastoma During Hypoxia Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.130  0.603
2017 Lodi A, Saha A, Lu X, Wang B, Sentandreu E, Collins M, Kolonin MG, DiGiovanni J, Tiziani S. Erratum: Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. Npj Precision Oncology. 1: 30. PMID 29873330 DOI: 10.1038/s41698-017-0027-9  0.617
2017 Lodi A, Saha A, Lu X, Wang B, Sentandreu E, Collins M, Kolonin MG, DiGiovanni J, Tiziani S. Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. Npj Precision Oncology. 1. PMID 29202102 DOI: 10.1038/s41698-017-0024-z  0.635
2017 Jose J, Tavares CDJ, Ebelt ND, Lodi A, Edupuganti R, Xie X, Devkota AK, Kaoud TS, Van Den Berg CL, Anslyn EV, Tiziani S, Bartholomeusz C, Dalby KN. Serotonin Analogues as Inhibitors of Breast Cancer Cell Growth. Acs Medicinal Chemistry Letters. 8: 1072-1076. PMID 29057053 DOI: 10.1021/Acsmedchemlett.7B00282  0.644
2017 Pandey R, Caflisch L, Lodi A, Brenner AJ, Tiziani S. Metabolomic signature of brain cancer. Molecular Carcinogenesis. PMID 28618012 DOI: 10.1002/Mc.22694  0.669
2017 Lu X, Solmonson A, Lodi A, Nowinski SM, Sentandreu E, Riley CL, Mills EM, Tiziani S. The early metabolomic response of adipose tissue during acute cold exposure in mice. Scientific Reports. 7: 3455. PMID 28615704 DOI: 10.1038/S41598-017-03108-X  0.653
2017 Baran N, Han L, Sweeney SR, Lodi A, Herbrich S, Cavazos A, Ma H, Feng N, Chen H, Kaminski M, Dunner K, Tang G, Alatrash G, Molina J, Guzman ML, ... ... Tiziani S, et al. Inhibition of Oxphos with Iacs-010759 Depletes AML Leukemia Initiating Cells (LIC) in Vitro and Improves Survival in Pre-Clinical AML Models Blood. 130: 1350-1350. DOI: 10.1182/Blood.V130.Suppl_1.1350.1350  0.648
2017 Quach DK, Harlow B, Winikka L, Brenner A, Beeram M, Tiziani S, Lengfelder L, Galvan G, Jolly C, deGraffenried L. Abstract 233: The impact of omega-3 fatty acid supplementation on obesity-induced inflammatory signaling within the breast tumor microenvironment Cancer Research. 77: 233-233. DOI: 10.1158/1538-7445.Am2017-233  0.303
2017 Saha A, Cramer SL, Kshattry S, Tiziani S, Stone E, Georgiou G, DiGiovanni J. Abstract 2132: Novel therapeutic approach through systemic depletion of L-cyst(e)ine with engineered cyst(e)inase enzyme for suppression of prostate tumor growth Cancer Research. 77: 2132-2132. DOI: 10.1158/1538-7445.Am2017-2132  0.37
2017 Kshattry S, Saha A, Cramer S, DiGiovanni J, Tiziani S, Munoz N, Georgiou G, Stone E. Abstract 105: Depletion of extracellular cystine and cysteine by a mutagenized human enzyme causes ROS mediated cytotoxicity in pancreatic cancer cells Cancer Research. 77: 105-105. DOI: 10.1158/1538-7445.Am2017-105  0.306
2017 Caflisch L, Lodi A, Gruslova A, Cavazos D, Garcia M, Tiziani S, Brenner A. METB-09. METABOLIC ADAPTATION TO CHRONIC HYPOXIA IN GLIOBLASTOMA CELLS Neuro-Oncology. 19: vi130-vi130. DOI: 10.1093/Neuonc/Nox168.533  0.661
2017 Gruslova A, Duque AD, Caflisch L, Tiziani S, Lodi A, Brenner A. DDIS-20. FASN INHIBITION AS A POTENTIAL TREATMENT TO PREVENT METABOLIC ADAPTATION IN GBM Neuro-Oncology. 19: vi63-vi63. DOI: 10.1093/Neuonc/Nox168.255  0.666
2017 Baran N, Lodi A, Sweeney S, Kuruvilla VM, Cavazos A, Velandy SS, Harutyunyan K, Feng N, Gay J, Kaminski M, Jabbour EJ, Ferrando A, Di Francesco ME, Tiziani S, Marszalek JR, et al. Targeting the Mitochondria Metabolism of T-ALL with Novel Mitochondrial Complex I Inhibitor IACS-010759 Clinical Lymphoma Myeloma and Leukemia. 17: S1-S2. DOI: 10.1016/J.Clml.2017.09.024  0.652
2017 Baran N, Han L, Herbrich S, Sweeney SR, Lodi A, Gay J, Feng N, Molina JR, Kaminski M, Guzman ML, Al-Atrash G, Tiziani S, Marszalek JR, Konopleva M. Novel Complex I inhibitor IACS-010759 Targets Leukemia Initiating Cells (LICs) in AML Patients Clinical Lymphoma Myeloma and Leukemia. 17: S297. DOI: 10.1016/J.Clml.2017.07.089  0.646
2017 Cai T, Lorenzi P, Rakheja D, Pontikos M, Lodi A, Han L, Zhang Q, Ma H, Rahmani M, Bhagat T, Horvath T, DiNardo C, Grant S, Tiziani S, Verma A, et al. GLS Inhibitor CB-839 Modulates Cellular Metabolism in AML and Potently Suppresses AML Cell Growth when Combined with 5-Azacitidine Clinical Lymphoma Myeloma and Leukemia. 17: S285-S286. DOI: 10.1016/J.Clml.2017.07.070  0.687
2016 Cramer SL, Saha A, Liu J, Tadi S, Tiziani S, Yan W, Triplett K, Lamb C, Alters SE, Rowlinson S, Zhang YJ, Keating MJ, Huang P, DiGiovanni J, Georgiou G, et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nature Medicine. PMID 27869804 DOI: 10.1038/Nm.4232  0.348
2016 Matre P, Velez J, Jacamo R, Qi Y, Su X, Cai T, Chan SM, Lodi A, Sweeney SR, Ma H, Davis RE, Baran N, Haferlach T, Su X, Flores ER, ... ... Tiziani S, et al. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes. Oncotarget. PMID 27806325 DOI: 10.18632/Oncotarget.12944  0.698
2016 Sweeney SR, Kavanaugh A, Lodi A, Wang B, Boyle D, Tiziani S, Guma M. Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis. Rmd Open. 2: e000289. PMID 27651926 DOI: 10.1136/Rmdopen-2016-000289  0.648
2016 Lashinger LM, O'Flanagan CH, Dunlap SM, Rasmussen AJ, Sweeney S, Guo JY, Lodi A, Tiziani S, White E, Hursting SD. Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumors. Cancer & Metabolism. 4: 18. PMID 27651895 DOI: 10.1186/S40170-016-0158-4  0.666
2016 Guma M, Tiziani S, Firestein GS. Metabolomics in rheumatic diseases: desperately seeking biomarkers. Nature Reviews. Rheumatology. 12: 269-81. PMID 26935283 DOI: 10.1038/Nrrheum.2016.1  0.356
2016 Garcia-Carbonell R, Divakaruni AS, Lodi A, Vicente-Suarez I, Saha A, Cheroutre H, Boss GR, Tiziani S, Murphy AN, Guma M. Critical role of fibroblast-like synoviocytes glycolytic metabolism in rheumatoid arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26815411 DOI: 10.1002/Art.39608  0.654
2016 Cai T, Lorenzi PL, Rakheja D, Pontikos MA, Lodi A, Han L, Zhang Q, Ma H, Rahmani M, Bhagat TD, Horvath TD, DiNardo CD, Grant S, Tiziani S, Verma A, et al. Gls Inhibitor CB-839 Modulates Cellular Metabolism in AML and Potently Suppresses AML Cell Growth When Combined with 5-Azacitidine Blood. 128: 4064-4064. DOI: 10.1182/Blood.V128.22.4064.4064  0.699
2016 Baran N, Molina J, Cavazos A, Harutyunyan K, Feng N, Gay J, Piya S, Shanmuga Velandy S, Jabbour EJ, Andreeff M, Tiziani S, Ferrando AA, Zweidler-McKay P, Di Francesco ME, Marszalek JR, et al. Mitochondrial Complex I Inhibition with Iacs-010759 in T-ALL Preclinical Models Blood. 128: 4028-4028. DOI: 10.1182/Blood.V128.22.4028.4028  0.405
2016 Sweeney SR, Sentandreu E, Tiziani S. Abstract 3: Amino acid profiles indicate dependence on different metabolic pathways between leukemia subtypes Cancer Research. 76: 3-3. DOI: 10.1158/1538-7445.Am2016-3  0.409
2016 Lu X, Wang B, Saha A, Sentandreu E, Lodi A, DiGiovanni J, Tiziani S. Abstract 12: Combinatorial intervention with natural compounds induces key metabolic modulations for prostate cancer prevention and treatment Cancer Research. 76: 12-12. DOI: 10.1158/1538-7445.Am2016-12  0.693
2015 Purać J, Kojić D, Popović ŽD, Vukašinović E, Tiziani S, Günther UL, Grubor-Lajšić G. Metabolomic Analysis of Diapausing and Noni-diapausing Larvae of the European Corn Borer Ostrinia nubilalis (Hbn.) (Lepidoptera: Crambidae). Acta Chimica Slovenica. 62: 761-7. PMID 26680702 DOI: 10.17344/Acsi.2015.1370  0.311
2015 Guma M, Sanchez-Lopez E, Lodi A, Garcia-Carbonell R, Tiziani S, Karin M, Lacal JC, Firestein GS. Choline kinase inhibition in rheumatoid arthritis. Annals of the Rheumatic Diseases. 74: 1399-407. PMID 25274633 DOI: 10.1136/Annrheumdis-2014-205696  0.649
2014 Kang Y, Tiziani S, Park G, Kaul M, Paternostro G. Cellular protection using Flt3 and PI3Kα inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity. Nature Communications. 5: 3672. PMID 24739485 DOI: 10.1038/Ncomms4672  0.325
2014 Matre P, Protopopova M, Feng N, Gay J, Greer J, Velez J, Mu H, Lodi A, Tadi S, Sweeney S, Andreeff M, Tiziani S, DiFrancesco ME, Marszalek J, Konopleva M. Novel Nanomolar Potency Mitochondrial Complex I Inhibitor Iacs-1131 Selectively Kills Oxphos-Dependent AML Cells Blood. 124: 622-622. DOI: 10.1182/Blood.V124.21.622.622  0.694
2014 Cavazos D, Gruslova A, Sun J, Floyd JR, Fichtel L, Tadi S, Lodi A, Tiziani S, Hart CP, Eng C, Brenner A. DD-02 * PHARMACODYNAMIC BIOMARKER ASSESSMENTS IN A PHASE I/II TRIAL OF THE HYPOXIA-ACTIVATED PRODRUG TH-302 AND BEVACIZUMAB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA Neuro-Oncology. 16: v60-v60. DOI: 10.1093/Neuonc/Nou246.2  0.639
2014 Brenner A, Floyd J, Eng C, Kroll S, Fichtel L, Gruslova A, Lodi A, Tiziani S. At-12Phase 1/2 Study Of Th-302, Investigational Hypoxia-Activated Prodrug, And Bevacizumab In Patients With Bevacizumab-Refractory Recurrent Glioblastoma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou237.12  0.618
2013 Tiziani S, Kang Y, Harjanto R, Axelrod J, Piermarocchi C, Roberts W, Paternostro G. Metabolomics of the tumor microenvironment in pediatric acute lymphoblastic leukemia. Plos One. 8: e82859. PMID 24349380 DOI: 10.1371/Journal.Pone.0082859  0.404
2013 Lodi A, Tiziani S, Khanim FL, Günther UL, Viant MR, Morgan GJ, Bunce CM, Drayson MT. Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease. Plos One. 8: e56422. PMID 23431376 DOI: 10.1371/Journal.Pone.0056422  0.646
2012 Ludwig C, Easton JM, Lodi A, Tiziani S, Manzoor SE, Southam AD, Byrne JJ, Bishop LM, He S, Arvanitis TN, Günther UL, Viant MR. Birmingham Metabolite Library: A publicly accessible database of 1-D 1H and 2-D 1H J-resolved NMR spectra of authentic metabolite standards (BML-NMR) Metabolomics. 8: 8-18. DOI: 10.1007/S11306-011-0347-7  0.632
2011 Tiziani S, Kang Y, Choi JS, Roberts W, Paternostro G. Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library. Nature Communications. 2: 545. PMID 22109519 DOI: 10.1038/Ncomms1562  0.388
2011 Lodi A, Tiziani S, Khanim FL, Drayson MT, Günther UL, Bunce CM, Viant MR. Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulation. Acs Chemical Biology. 6: 169-75. PMID 20886892 DOI: 10.1021/Cb900300J  0.705
2009 Romanska HM, Tiziani S, Howe RC, Günther UL, Gulzar Z, Lalani el-N. Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts. Neoplasia (New York, N.Y.). 11: 1301-8. PMID 20019838 DOI: 10.1593/Neo.09850  0.398
2009 Khanim FL, Hayden RE, Birtwistle J, Lodi A, Tiziani S, Davies NJ, Ride JP, Viant MR, Gunther UL, Mountford JC, Schrewe H, Green RM, Murray JA, Drayson MT, Bunce CM. Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. Plos One. 4: e8147. PMID 19997560 DOI: 10.1371/Journal.Pone.0008147  0.669
2009 Tiziani S, Lopes V, Günther UL. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia (New York, N.Y.). 11: 269-76, 4p following. PMID 19242608 DOI: 10.1593/Neo.81396  0.329
2009 Tiziani S, Lodi A, Khanim FL, Viant MR, Bunce CM, Günther UL. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. Plos One. 4: e4251. PMID 19158949 DOI: 10.1371/Journal.Pone.0004251  0.688
2009 Tiziani S, Lodi A, Khanim FL, Viant MR, Bunce CM, Günther UL. Correction: Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines Plos One. 4. DOI: 10.1371/Annotation/39584D38-04F5-4B37-Bfd8-Eae2318Ec6F9  0.624
2008 Tiziani S, Emwas AH, Lodi A, Ludwig C, Bunce CM, Viant MR, Günther UL. Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Analytical Biochemistry. 377: 16-23. PMID 18312846 DOI: 10.1016/J.Ab.2008.01.037  0.636
2008 Tiziani S, Lodi A, Ludwig C, Parsons HM, Viant MR. Effects of the application of different window functions and projection methods on processing of 1H J-resolved nuclear magnetic resonance spectra for metabolomics. Analytica Chimica Acta. 610: 80-8. PMID 18267143 DOI: 10.1016/J.Aca.2008.01.030  0.611
2008 Tiziani S, Schwartz SJ, Vodovotz Y. Intermolecular interactions in phytochemical model systems studied by NMR diffusion measurements Food Chemistry. 107: 962-969. DOI: 10.1016/J.Foodchem.2007.08.089  0.577
2007 Lodi A, Tiziani S, Vodovotz Y. Molecular changes in soy and wheat breads during storage as probed by nuclear magnetic resonance (NMR). Journal of Agricultural and Food Chemistry. 55: 5850-7. PMID 17579434 DOI: 10.1021/Jf070636A  0.715
2006 Tiziani S, Schwartz SJ, Vodovotz Y. Profiling of carotenoids in tomato juice by one- and two-dimensional NMR. Journal of Agricultural and Food Chemistry. 54: 6094-100. PMID 16881722 DOI: 10.1021/Jf061154M  0.589
2005 Tiziani S, Vodovotz Y. Rheological characterization of a novel functional food: tomato juice with soy germ. Journal of Agricultural and Food Chemistry. 53: 7267-73. PMID 16131141 DOI: 10.1021/Jf0511087  0.566
2005 Tiziani S, Vodovotz Y. Rheological effects of soy protein addition to tomato juice Food Hydrocolloids. 19: 45-52. DOI: 10.1016/J.Foodhyd.2004.04.012  0.562
Show low-probability matches.